What do you see as the value proposition for Nastech going forward with respect to both nasal business as well as RNAi? Stephen Quay. Well, as indicated today through a fairly ...

With only $58 million in the bank at the end of last quarter, Nastech is going to have to make some tough decisions on which of its four unpartnered clinical stage programs it's ...

Cramer says the drug company has 'so many ways to win.' ... Here's what Jim Cramer had to say about some of the stocks that callers offered up during the "Mad Money Lightning Round ...

THE COLLATERAL DAMAGE IS SO EXTENSIVE THAT EVEN HAVING A NEW CEO, MR.FRENCH, ISN'T GOING ... But now she gives NSTK once again, a new 4 Star Rating after the stock reached another ...

Comments on recent NSTK articles jimmy t on Jul 13, 2008 at 09:49 AM Investors who bought at ... free, live high on the hog, and accomplish more in a lifetime than they could going to ...

This is a breakthrough because nasal administration is going to be theoretically more acceptable to patients." Mease has consulted for Nastech but not for this nasal spray.

Bothell's Nastech Pharmaceutical says it will lay off workers and spin off its RNA ... Restaurants/Dining; Music; Local Bands; Books; Video Games; Theater/Fine Arts; People; A&E Wire; Going ...

In any case, Nastech is going ahead with a flu program gained through the buyout of intellectual property from Galenea Corp., though Quay declined to provide time lines.

Nastech Pharmaceutical Company Inc. Complies with Nasdaq Marketplace Rule 4350 from ... which requires separate disclosure of receipt of an audit opinion that contains a going ...

BOTHELL, Wash.--(Business Wire)-- Nastech Pharmaceutical Company Inc. (Nasdaq: ... which requires separate disclosure of receipt of an audit opinion that contains a going ...

04-2008 - NASTech completes the installation of P-DAQ at Hamilton Printing ... with RRD and we wish all at Von Hoffmann continuing success going ...

Forum discussion titled Nastech Pharm. (NSTK): m100 Top Buy about NSTK ... Depends on the fundamentals going forward - and that's anyones guess.

On March 3, 2008, Nastech Pharmaceutical Company Inc. (the "Company") held a conference call to discuss the Company's corporate restructuring initiatives and strategy going forward

Nastech Pharmaceutical Inc. (NASDAQ:NSTK) is supposed to win from an intranasal delivery ... It has trials going for diabetes and obesity, and the bad quarter doesn't kill its ...

Nastech and P&G believe that the additional data resulting from the on-going and planned studies are important for the FDA regulatory pathway.

BOTHELL, Wash.--(BUSINESS WIRE)--Nastech Pharmaceutical Company Inc. (Nasdaq: ... which requires separate disclosure of receipt of an audit opinion that contains a going ...

Obviously, I have been about as wrong on Nastech as I have ever been on anything. ... If they think PTH has no chance of going forward, they won't waste the company's ...

I guess posters were right about nstk, and I wouldn't want to be in Jim Cramer's shoes now ... are down 10% or more in the last year but may be poised to surprise us on the upside going ...

If Boyko's ruling stands and is used as a model in other states, life is going to get very complicated indeed. The latest on Nastech Finally, for anyone with an interest in Nastech ...

Nastech (NSTK) CEO Steven Quay ... announced that the planned spin-off of the company's RNAi technology wasn't going to happen ... With one partner and product failure after ...

... on Monday, March 3, 2008 BOTHELL, Wash., Feb. 29 /PRNewswire-FirstCall/ -- Nastech ... Are you going to the conventions?

I think that is what folks ought to expect from Nastech: It's going to be a boring stock to watch, except for those days when news moves it a whole bunch.

Short Selling Volatile Biotechs (June 2007) (DNDN, NFLD, NSTK, ADLR, ALTH, COLY, CEGE ... Allos Therapeutics (ALTH) didn't implode, but it looked like it was going to.

... Steven Quay announced that the planned spin-off of the company's RNAi technology wasn?t going to happen. (Read Fleck?s good description of this technology as Nastech sees it ...

Crocs (CROX) and Nastech Pharm (NSTK) volatility up on larger sell offs ... Drop dead (54) Going down in flames: Capitalism, American-style (46) If John McCain is afraid ...

Recent Channel Execs Coming And Going ... Nastech Pharmaceutical Company Inc. announced today that it has entered into definitive ...

Recent Channel Execs Coming And Going. It's been a busy quarter for shakeups in some of the ... Nastech Pharmaceutical Company Inc. (NSTK) Q2 2008 Earnings Call ...

nstk: where is the balance for investors? ... recently they were going to have a new subsidiary, and then last week an articles came out ...

Obviously, I have been about as wrong on Nastech (NSTK) as I have ever been on anything. ... If they think PTH has no chance of going forward, they won't waste the company's ...

... s latest quarter, so Cramer brought Chairman, CEO and President Dr. Steven Quay on Mad Money to find out what was going on. Watch the video to get Quay's outlook on Nastech's